Search PubMed⌕ Search

Biomedical subjects

N Li

Publications and source records attributed to N Li.

At least 73 records · Page 4Linked to original sources
PubMed2004

Increased body weight via injecting myogenic expression growth hormone-releasing hormone (GHRH) plasmid DNA into sheep.

The ectopic expression of a sheep growth hormone-releasing hormone (GHRH) from muscle tissues, using a myogenic plasmid expression vector pM-GHRH, has been shown to result in enhanced animal growth. Animal injected with pM-GHRH alone exhibited a daily weight gain rate of 0.84+/-0.02%/d (p < 0.05), while that of the control animal was only 0.73+/-0.04%/d. A more significant growth enhancement was observed in the group treated with pM-GHRH plus 0.25% bupivacaine. The animal displayed a daily weight gain rate of 0.87+/-0.03%/d (p<0.01). In addition, the group treated by pM-GHRH and bupivacaine had higher levels of growth hormone (GH) in their blood (1.18+/-0.33 ng/mL) compared with the group treated by pM-GHRH vector alone (p < 0.05). Evaluation of body composition by dissection and histochemical analysis indicated a significant increase in bulk with no organomegaly or associated pathology. PCR analysis demonstrated that there was little plasmid residue detected in the pM-GHRH treated sheep.

Animals↗
PubMed2004

PRNP polymorphisms in Chinese ovine, caprine and bovine breeds.

Transmissible spongiform encephalopathy (TSE) is a neurodegenerative disorder in humans and animals. Polymorphisms and mutations in the prion protein (PRNP) gene have been associated with the incidence of natural and experimental TSE and the incubation period length. In this study, we determined PRNP polymorphisms in Chinese ovine, caprine and bovine breeds using 400 samples from 13 ovine and caprine breeds and 250 samples from nine bovine breeds. In the ovine and caprine PRNP gene, we found five previously unreported amino acid polymorphisms and two silent nucleotide alterations. In bovine PRNP, we found eight previously unreported amino acid polymorphisms and six silent nucleotide alterations.

Amyloid↗
PubMed2004

Enhanced leukocyte-platelet cross-talk in Type 1 diabetes mellitus: relationship to microangiopathy.

BACKGROUND: Platelets and leukocytes may influence each others' function, i.e. platelet-leukocyte cross-talk. Diabetes mellitus (DM) is associated with platelet and leukocyte dysfunction. OBJECTIVE: To evaluate platelet-leukocyte cross-talk, and if this might contribute to platelet and leukocyte dysfunction and microangiopathy in DM patients. PATIENTS AND METHODS: We evaluated platelet and leukocyte function, and cross-talk between these cells in Type 1 DM patients without (n = 19) and with (n = 20) microangiopathy, and healthy subjects (n = 27), using whole blood flow cytometry. Platelet-leukocyte cross-talk was studied in hirudinized whole blood incubated at 37 degrees C with stirring. RESULTS: Basal single platelet P-selectin and leukocyte CD11b expression were similar in DM patients and healthy subjects, whilst circulating platelet-leukocyte aggregates and plasma elastase levels were elevated in DM patients. The thromboxane A2 analog U46619 (3 x 10(-7) m) induced more marked increases of platelet P-selectin expression and platelet-leukocyte aggregation in DM patients than in healthy subjects. The leukocyte-specific agonist N-formyl-methionyl-leucyl-phenylalanine (fMLP) (10(-7) m) induced more marked CD11b expression in DM patients with microangiopathy, compared with healthy subjects. Platelet-leukocyte cross-talk induced by U46619 (10(-6) m) showed no difference between DM patients and healthy subjects. fMLP (10(-6) m) evoked marked leukocyte activation, which subsequently caused mild platelet P-selectin expression. This leukocyte-platelet cross-talk was more pronounced in DM patients than in healthy subjects. Furthermore, enhanced leukocyte-platelet cross-talk was correlated to platelet hyperreactivity among DM patients with microangiopathy only. CONCLUSIONS: Type 1 DM is associated with platelet and leukocyte hyperactivity, and enhanced leukocyte-platelet cross-talk, which may contribute to platelet hyperactivity and the microvascular complications seen in Type 1 DM.

Adult↗
PubMed2004

Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma.

AIMS: Several studies have shown the presence of helicobacter species in the human biliary tract and in the intestinal tract of animals. Experimental infection by Helicobacter hepaticus in mice causes chronic hepatitis and hepatocellular carcinoma (HCC). This study investigated whether helicobacter species could be detected in the liver of patients with HCC. METHODS: Liver samples from 20 patients with primary liver carcinoma diagnosed by histopathology and 16 controls without primary liver carcinoma were studied. Histology with standard and immunohistochemical stains, culture, and polymerase chain reaction (PCR) amplification using helicobacter genus specific 16S rRNA primers were used to detect the presence of bacteria. Amplified products were identified by Southern hybridisation and sequencing. A search for other genes specific for Helicobacter pylori was also performed. RESULTS: Helicobacter species 16S rDNA was found in eight of 20 samples of primary liver carcinoma, whereas none of the controls harboured this rDNA. Six helicobacter specific PCR amplicons were sequenced and were found to have 98.5-99.0% similarity to the 16S rDNA of H pylori. Of the eight positive samples, seven were positive in PCR using 26 kDa protein primers and six showed morphological and immunohistochemical evidence of H pylori. The cagA and glmM genes were detected in only two samples. The vacA and rps4 genes were not detected. CONCLUSIONS: Helicobacter can be present in the liver of patients with primary liver carcinoma and is probably linked to the carcinogenic process in the liver.

Adult↗
PubMed2003

Use of stable emulsion to improve stability, activity, and enantioselectivity of lipase immobilized in a membrane reactor.

The enantiocatalytic performance of immobilized lipase in an emulsion membrane reactor using stable emulsion prepared by membrane emulsification technology was studied. The production of optical pure (S)-naproxen from racemic naproxen methyl ester was used as a model reaction system. The O/W emulsion, containing the substrate in the organic phase, was fed to the enzyme membrane reactor from shell-to-lumen. The enzyme was immobilized in the sponge layer (shell side) of capillary polyamide membrane with 50 kDa cut-off. The aqueous phase was able to permeate through the membrane while the microemulsion was retained by the thin selective layer. Therefore, the substrate was kept in the enzyme-loaded membrane while the water-soluble product was continuously removed from the reaction site. The results show that lipase maintained stable activity during the entire operation time (more than 250 h), showing an enantiomeric excess (96 +/- 2%) comparable to the free enzyme (98 +/- 1%) and much higher compared to similar lipase-loaded membrane reactors used in two-separate phase systems (90%). The results demonstrate that immobilized enzymes can achieve high stability as well as high catalytic activity and enantioselectivity.

Bioreactors↗
PubMed2003

Manipulation of dopamine d1-like receptor activation in the rat medial prefrontal cortex alters stress- and cocaine-induced reinstatement of conditioned place preference behavior.

These studies examined the ability of the dopamine D1-like agonist SKF 81297 and D1-like antagonist SCH 23390 in the medial prefrontal cortex to alter the reinstatement of cocaine-induced conditioned place preference behavior. Male Sprague-Dawley rats were fitted with bilateral cannulae over the medial prefrontal cortex and subsequently trained in a conditioned place preference task. Animals were trained in this task using four pairings of cocaine (12 mg/kg, i.p.). Conditioned place preference was demonstrated in all animals, and this behavior was then extinguished over a 5-10-day period before testing for reinstatement. Just prior to reinstatement by immobilization stress or a cocaine priming injection (5 mg/kg, i.p.), a microinjection of the D1-like receptor antagonist SCH 23390 (0.01, 0.1 or 1.0 microg/side), or the D1-like receptor agonist SKF 81297 (0.1, 0.3 or 1.0 microg/side) was given into the medial prefrontal cortex. SCH 23390 blocked both stress- and cocaine-induced reinstatement of conditioned place preference after the two higher doses were administered into the medial prefrontal cortex. The highest dose of SKF 81297 (1.0 microg/side) prevented immobilization stress- but not cocaine-induced reinstatement. The highest dose of these drugs given in the absence of stress or cocaine did not produce reinstatement. The results indicate that immobilization stress given within the place-preference chamber is capable of producing reinstatement of cocaine-seeking behavior. The microinjection studies suggest that D1-like receptor antagonism within the prefrontal cortex is sufficient to block reinstatement by stress and cocaine. Furthermore, the results from D1-like receptor activation in the medial prefrontal cortex point to utilization of different neural pathways for stress- and cocaine-induced reinstatement.

Animals↗
PubMed2003

Regulator T cells: specific for antigen and/or antigen receptors?

Adaptive immune responses are regulated by many different molecular and cellular effectors. Regulator T cells are coming to their rights again, and these T cells seem to have ordinary alpha/beta T-cell receptors (TCRs) and to develop in the thymus. Autoimmune responses are tightly regulated by such regulatory T cells, a phenomenon which is beneficial to the host in autoimmune situations. However, the regulation of autoimmune responses to tumour cells is harmful to the host, as this regulation delays the defence against the outgrowth of neoplastic cells. In the present review, we discuss whether regulatory T cells are specific for antigen and/or for antigen receptors. Our interest in these phenomena comes from the findings that T cells produce many more TCR-alpha and TCR-beta chains than are necessary for surface membrane expression of TCR-alphabeta heterodimers with CD3 complexes. Excess TCR chains are degraded by the proteasomes, and TCR peptides thus become available to the assembly pathway of major histocompatibility complex class I molecules. Consequently, do T cells express two different identification markers on the cell membrane, the TCR-alphabeta clonotype for recognition by B-cell receptors and clonotypic TCR-alphabeta peptides for recognition by T cells?

Amino Acid Sequence↗
PubMed2003

Biphasic pro-thrombotic and inflammatory responses after coronary artery bypass surgery.

Early graft failure after coronary artery bypass grafting (CABG) is related to thrombosis and inflammation in the grafted vessel(s). The time courses of, and relationships between, pro-thrombotic and inflammatory responses to CABG surgery have, however, not been well defined. Fifteen patients undergoing CABG were examined before, and 1 h, 1 day, 7 days, and 3 months after surgery. Cellular markers of platelet and leukocyte activation were monitored by whole blood flow cytometry, and plasma markers of pro-thrombotic and inflammatory responses were analyzed by immunoassays. CABG immediately increased circulating P-selectin-positive platelets, leukocyte CD11b expression, and platelet-leukocyte aggregates (PLAs). Thrombin generation (F1 + 2 levels) and cytokine release [tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-8, and IL-10], soluble P-selectin, and soluble E-selectin also increased immediately. These alterations persisted during the first week after surgery, with re-bound increases of circulating activated platelets and PLAs, TNF-alpha, and F1 + 2 on day 7. Platelet and PLA responsiveness to in vitro stimulation was suppressed immediately after CABG, but markedly enhanced 1 week after surgery. After 3 months, plasma soluble P-selectin, F1 + 2, and IL-10, and monocyte CD11b expression were still slightly elevated compared with baseline. In conclusion, CABG induces marked pro-thrombotic and inflammatory responses, which persist for at least 1 week. Platelet activation, platelet reactivity, PLA formation, thrombin generation, and TNF-alpha release show a second peak 1 week after surgery. These findings suggest that intensified and prolonged antithrombotic/inflammatory treatment should be considered after CABG surgery.

Aged↗
PubMed2003

Glycoprotein IIb/IIIa inhibition attenuates platelet-activating factor-induced platelet activation by reducing protein kinase C activity.

Glycoprotein (GP)IIb/IIIa inhibition may abolish activated leukocyte-induced platelet activation, in which leukocyte-released platelet-activating factor (PAF) is a major mediator. The present study thus investigated if and how GPIIb/IIIa inhibitors interfere with PAF-induced platelet activation. Platelet and leukocyte activation were monitored by flow cytometry and immunoblotting. GPIIb/IIIa inhibitors (c7E3, non-peptide SR121566, and MAb RFGP56) attenuated PAF-induced, but not adenosine diphosphate (ADP)- or thrombin receptor activating peptide (TRAP)-induced platelet P-selectin expression in whole blood. GPIIb/IIIa blockade enhanced ADP- or TRAP-induced leukocyte CD11b expression, but not the response to PAF. GPIIb/IIIa blockade attenuated PAF-induced, but enhanced ADP- or TRAP-induced platelet-leukocyte aggregation. Under the present experimental conditions, thromboxane A2 receptor antagonism did not significantly influence PAF-induced platelet activation, and GPIIb/IIIa inhibition did not interfere with calcium mobilization/influx in platelets. Protein kinase C (PKC) blockade inhibited PAF-induced platelet P-selectin expression, and PAF-induced PKC activity was reduced by GPIIb/IIIa inhibition. PAF (=1 micro m) did not induce MEK 1/2 or ERK 1/2 phosphorylation, whilst thrombin induced marked responses, which were enhanced by GPIIb/IIIa blockade. Thus, GPIIb/IIIa inhibition attenuates PAF-induced platelet activation via inhibiting PKC activity. GPIIb/IIIa blockade enhances thrombin-induced platelet MEK 1/2 and ERK 1/2 activation, and augments ADP- and TRAP-induced leukocyte activation by enhancing platelet-leukocyte aggregation.

Adenosine Diphosphate↗
PubMed2003

Differences in morphine and cocaine reinforcement under fixed and progressive ratio schedules; effects of extinction, reacquisition and schedule design.

Opiate reinforcement was evaluated under a progressive ratio (PR) schedule often used for psychostimulant self-administration (termed 'PR 3-4' because the third response requirement was four lever presses) and three additional schedules that were modified to provide successively lower levels of difficulty by decreasing the steepness of response requirement progression (termed 'PR 9-4', 'PR 14-4', and 'PR 26-4' because a response requirement of four was reached with step numbers of 9, 14 and 26, respectively). With the exception of the PR 3-4 schedule, all of the schedules supported morphine self-administration, and morphine self-administration during initial exposure and reacquisition did not differ by more than 10%. In contrast to morphine, cocaine was self-administered under the PR 3-4 schedule, with responding clearly exceeding levels during extinction. The PR 9-4 schedule was most suitable for morphine self-administration because it provided an intermediate level of difficulty, which supported levels of self-administration that exceeded values obtained under extinction but were less than those observed under FR-1. Under the PR 9-4 schedule, the number of self-administered injections of morphine was 61.5% of the number of injections obtained under a simple FR-1 schedule. This compares with a value of 21.0% for cocaine self-administration under the PR 3-4 schedule compared to an FR-1 schedule. These results show important differences in self-administration behavior supported by morphine and cocaine, which are consistent with a lower reinforcing efficacy for opiates relative to psychostimulants.

Animals↗
PubMed2003

Development of a model to describe the compositional growth and dietary lysine requirements of pigs fed ractopamine.

The objective of this research was to use recent ractopamine research data to develop an updated mathematical model to describe the daily compositional growth of pigs fed ractopamine. Mean increases of 18.2, 23.1, and 25.0% for daily protein accretion were assumed for 5, 10, and 20 ppm of ractopamine for an overall gain of 40 kg of BW gain during the feeding period. The relative effect of ractopamine described the rapid increase and subsequent decrease in the effect of ractopamine as a function of BW gain or days on test and ractopamine concentration (RC, ppm). The reduction in ME intake produced by ractopamine was described as 0.036 x (RC/20)(0.7) multiplied by the ME intake for the first 20 kg of BW gain, and then increasing to 0.078 x (RC/20)(0.7) at 40 kg of BW gain feeding period. The ratio of fat-free muscle gain to protein accretion increased by 14 to 16% with the feeding of ractopamine, depending on the dietary lysine/essential AA levels. The ratio of carcass fat gain to empty body lipid gain was increased when lysine and essential AA requirements were met. Daily protein accretion and fat-free lean growth were described as functions of dietary lysine/essential AA intakes. The percentage of lysine in protein accretion increased with the feeding of ractopamine from 6.80 to 7.15%, depending on ractopamine concentration. Equations predicting carcass measurements, such as fat and longissimus muscle depths from carcass weight and composition, were modified to incorporate prediction biases produced by ractopamine. For the four concentrations of ractopamine (0, 5, 10, and 20 ppm, respectively) during a 78 to 110 kg of BW feeding period, the model predicted performance levels for ADG (1.03, 1.15, 1.16, and 1.16 kg/d), gain:feed (kg of ADG/kg of ADFI; 0.360, 0.401, 0.412, and 0.425), dressing percentage (75.1, 76.0, 76.3, and 76.4), percentage fat-free lean (48.7, 51.0, 51.5, and 52.2), longissimus muscle area (38.8,41.8,42.5, and 43.5 cm2), 10th-rib fat depth (22.1, 19.8, 19.3, and 18.7 mm), and fat-free lean gain (321, 446, 467, and 495 g/d), comparable to recent research data. The model allows the effect of ractopamine to be added to farm specific pig growth curves. It can be used to evaluate ways to optimize the use of ractopamine, including duration of ractopamine feeding, concentration of ractopamine, and dietary lysine concentration.

Adipose Tissue↗
PubMed2002

Facial subdermal vascular network flap: anatomic study and clinical application.

Despite the numerous flaps for facial reconstruction that have been described, the search for the ideal flap with good color matching and minimal donor-site morbidity continues. In the past 3 years we have repaired 13 facial defects with success using the lateral genicervical flap - a type of facial subdermal vascular network flap (SVNF) - with a pedicle located on the preauricular region. An anatomic study of the facial SVNF, including blood supply and vascular distribution of the face and anatomic characteristics of facial vessels, based on 14 cadaver dissections, was carried out. The blood supply of the facial skin basically originated from the branches of the facial, superficial temporal and infraorbital arteries. The lateral genicervical skin was supplied basically by the branches of the facial, superficial temporal and occipital arteries, but also by the terminal branches of the superior thyroid artery. The branches diverging from these arteries became superficial and formed a subcutaneous arterial network. The arterioles from the network went to the corium layer and formed a subdermal arterial network whose arterioles anastomosed with each other in a honeycomb-like structure. The vascular distribution presented certain directivity on different areas. The blood supply of the pedicle originated from the subdermal vascular network formed by the perforator branches of these arteries. The arterioles from the facial and superficial temporal arteries anastomosed in the lateral genicervical region. From the anatomic study, we think that the viability of the facial SVNF depends basically on the subdermal vascular network formed by the perforator branches of the pedicle, and that the anastomoses between the facial and superficial temporal arteries provide a solid anatomic basis to the lateral genicervical flap. The clinical data also indicated that this flap is a useful alternative for facial, especially superficial temporal, defects. But the directivity must be taken into account in its clinical application.

Adolescent↗
PubMed2002

Site-specific forms of antifreeze protein in the beetle Dendroides canadensis.

It was known previously that overwintering larvae of the beetle Dendroides canadensis produce antifreeze proteins (DAFPs) consisting of a family of 12 similar proteins, and based on sequence variations the DAFPs may be separated into three groups. DAFPs were known to be present in hemolymph, midgut fluid and in/on epidermal cells located immediately under the cuticle. However, only DAFPs-1, 2, and 4 were known to be present in the hemolymph, leaving the location of the others unknown. In this study, matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry of hemolymph confirmed the presence of DAFPs-1, 2, and 4 (Group I), plus a protein consistent with the mass of DAFP-6 (Group I). Also, a review of older data revealed the co-purification of DAFP-6 along with DAFP-4 in hemolymph. However, none of the other DAFPs (Groups II and III) were present in hemolymph. In contrast, mass spectrometry of midgut fluid demonstrated the absence of DAFPs-1, 2, 4, or 6, however, proteins consistent with the masses of all, or a subset of, Groups II and/or III were present. Reverse transcriptase polymerase chain reaction (RT-PCR) showed that transcripts of all 12 DAFPs were present in the fat body. However, consistent with the MALDI-TOF data, only Groups II (8, 9, 10, 11) and III (3, 5, 7, 12) transcripts were found in midgut epithelia. RT-PCR of epidermal tissue identified dafps- 4, 6, 8 and 11 (and sometimes 1 and/or 2) as the major transcripts. These data suggest that various DAFPs may have evolved to function best in certain sites.

Amino Acid Sequence↗